Metformin ameliorates BSCB disruption by inhibiting neutrophil infiltration and MMP‐9 expression but not direct TJ proteins expression regulation

Blood‐spinal cord barrier (BSCB) disruption is a major process for the secondary injury of spinal cord injury (SCI) and is considered to be a therapeutic target for SCI. Previously, we demonstrated that metformin could improve functional recovery after SCI; however, the effect of metformin on BSCB i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Di, Tang, Qian, Zheng, Gang, Wang, Chenggui, Zhou, Yifei, Wu, Yaosen, Xuan, Jun, Tian, Naifeng, Wang, Xiangyang, Wu, Yan, Xu, Huazi, Zhang, Xiaolei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706495/
https://www.ncbi.nlm.nih.gov/pubmed/28699677
http://dx.doi.org/10.1111/jcmm.13235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706495/
https://www.ncbi.nlm.nih.gov/pubmed/28699677
http://dx.doi.org/10.1111/jcmm.13235

Ejemplares similares